BCLI

BRAINSTORM CELL THERAPUTC
BCLI

Overview Fund Activity
Delisted

BCLI was delisted on the 17th of July, 2025.

Back to rankings

24 hedge funds and large institutions have $3.14M invested in BRAINSTORM CELL THERAPUTC in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.

Holders
24
Holders Change
+2
Holders Change %
+9.09%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
2
Closed
2
Calls
$4K
Puts
$98K
Net Calls
-$94K
Net Calls Change
-$94K

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.36M
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$51K
3
PVH
3
Psagot Value Holdings
Israel
$94K
4
Wells Fargo
4
Wells Fargo
California
$10K
5
DOA
5
D'Orazio & Associates
Virginia
$2K

Top Sellers

1
PA
1
Perceptive Advisors
New York
$0
2
SM
2
Sabby Management
Florida
$1.06M
3
UBS Group
3
UBS Group
Switzerland
$0
4
Bank of New York Mellon
4
Bank of New York Mellon
New York
$38K
Name Holding Trade Value Shares
Change 		Shares
Change %
UBS Group
26
UBS Group
Switzerland
– -$13K -359 Closed
1
2